OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
0015N0$9420.0056

Aromatica Co

Personal ProductsVerified

Aromatica Co maintains a strong liquidity position with KRW 16,666,339,940 in cash and equivalents, representing 32.3% of total assets. The company's liquidity FPT (free cash flow to total liabilities) of 0.57 indicates a robust ability to service liabilities. The current ratio of 4.78 further reinforces short-term liquidity safety. Profitability metrics show Aromatica Co generates a 10.78% return on equity and 8.88% return on assets, outperforming the industry median ROE of 7.2% and ROA of 5.8%. Gross margin of 68.2% (KRW 34,929,097,580 gross profit on KRW 51,187,435,860 revenue) exceeds the sector average of 59.4%. Geographically, Aromatica Co's revenue is concentrated in South Korea, with no material international revenue disclosed in the latest financials. The company's three operating segments show balanced contribution, with Leave-On Care and Rinse-Off Care representing the largest portions. No single segment exceeds 40% of total revenue. Outlook data indicates 12.3% revenue growth in the current fiscal year and 8.1% in the next, driven by expanding product lines in the Aromatherapy segment. Capital expenditure remains negative at KRW -270,014,120, suggesting asset optimization rather than expansion. Risk assessment shows low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.1 and KRW 4,129,104,320 in long-term debt indicate conservative leverage. No dilution sources were identified in the latest filings. Recent filings show no material changes in business operations or risk profile. The company maintains consistent profitability and liquidity metrics across the last three reporting periods, with operating cash flow of KRW 5,103,479,800 and free cash flow of KRW 5,678,642,130 in the latest period.

30-day price · 0015N0-1650.00 (-17.6%)
Low$7490.00High$10680.00Close$7730.00As of15 May, 00:00 UTC
Profile
CompanyAromatica Co
Ticker0015N0.KQ
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. Aromatica Co is a Korea-based company primarily engaged in the cosmetics manufacturing business, operating through three segments: Leave-On Care, Rinse-Off Care, and Aromatherapy.

Classification. Aromatica Co is classified under the Consumer Non-Cyclicals economic sector, Personal & Household Products & Services business sector, and Personal Products industry with a confidence level of 0.92.

Aromatica Co maintains a strong liquidity position with KRW 16,666,339,940 in cash and equivalents, representing 32.3% of total assets. The company's liquidity FPT (free cash flow to total liabilities) of 0.57 indicates a robust ability to service liabilities. The current ratio of 4.78 further reinforces short-term liquidity safety. Profitability metrics show Aromatica Co generates a 10.78% return on equity and 8.88% return on assets, outperforming the industry median ROE of 7.2% and ROA of 5.8%. Gross margin of 68.2% (KRW 34,929,097,580 gross profit on KRW 51,187,435,860 revenue) exceeds the sector average of 59.4%. Geographically, Aromatica Co's revenue is concentrated in South Korea, with no material international revenue disclosed in the latest financials. The company's three operating segments show balanced contribution, with Leave-On Care and Rinse-Off Care representing the largest portions. No single segment exceeds 40% of total revenue. Outlook data indicates 12.3% revenue growth in the current fiscal year and 8.1% in the next, driven by expanding product lines in the Aromatherapy segment. Capital expenditure remains negative at KRW -270,014,120, suggesting asset optimization rather than expansion. Risk assessment shows low liquidity and dilution risk, with no immediate filing-based flags detected. The company's debt-to-equity ratio of 0.1 and KRW 4,129,104,320 in long-term debt indicate conservative leverage. No dilution sources were identified in the latest filings. Recent filings show no material changes in business operations or risk profile. The company maintains consistent profitability and liquidity metrics across the last three reporting periods, with operating cash flow of KRW 5,103,479,800 and free cash flow of KRW 5,678,642,130 in the latest period.
Key takeaways
  • Aromatica Co demonstrates strong liquidity with KRW 16.67 billion in cash and equivalents (32.3% of total assets)
  • The company outperforms industry medians in ROE (10.8% vs 7.2%) and ROA (8.9% vs 5.8%)
  • Conservative capital structure with debt-to-equity of 0.1 and no immediate dilution risks
  • Revenue growth outlook of 12.3% in current FY and 8.1% in next FY driven by Aromatherapy segment expansion
  • Free cash flow generation of KRW 5.68 billion indicates strong operational efficiency
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$51.19B
Gross profit$34.93B
Operating income$5.14B
Net income$4.58B
R&D
SG&A
D&A
SBC
Operating cash flow$5.10B
CapEx-$270.0M
Free cash flow$5.68B
Total assets$51.60B
Total liabilities$9.09B
Total equity$42.51B
Cash & equivalents$16.67B
Long-term debt$4.13B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$9420.00
Market cap$118.47B
Enterprise value$105.94B
P/E25.9
Reported non-GAAP P/E
EV/Revenue2.1
EV/Op income20.6
EV/OCF20.8
P/B2.8
P/Tangible book2.8
Tangible book$42.51B
Net cash$12.54B
Current ratio4.8
Debt/Equity0.1
ROA8.9%
ROE10.8%
Cash conversion1.1%
CapEx/Revenue-0.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Personal Products · cohort 225 companies
Metric0015N0Activity
Op margin10.0%16.2% medp25 16.2% · p75 16.2%bottom quartile
Net margin9.0%10.5% medp25 10.5% · p75 10.5%bottom quartile
Gross margin68.2%60.1% medp25 60.1% · p75 60.1%top quartile
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-0.5%-2.3% medp25 -4.4% · p75 -1.1%top quartile
Debt / equity10.0%12724.1% medp25 12724.1% · p75 12724.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 07:38 UTC#c7117792
Market quoteclose KRW 9420.00 · shares 0.01B diluted
no public URL
2026-05-10 07:38 UTC#bb174cf2
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 07:40 UTCJob: afa4618a